The government named 10 drugs that will be subject to the first ever price negotiations by Medicare, taking aim at some of the most expensive and widely used medicines in the U.S.
Wall Street Journal
The government named 10 drugs that will be subject to the first ever price negotiations by Medicare, taking aim at some of the most expensive and widely used medicines in the U.S.